Clinical Trial Update: The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of moxonidine on blood pressure. The study also assesses regression of early target organ damage in young individua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• Moxonidine (moxonidine)

Snippet

Sponsor: Baker Heart and Diabetes Institute | Conditions: Abdominal Obesity, Hypertension | Phase 4 | Status: UNKNOWN